Literature DB >> 15851848

Differential loss of synaptic proteins in Alzheimer's disease: implications for synaptic dysfunction.

P Hemachandra Reddy1, Geethalakshmi Mani, Byung S Park, Joline Jacques, Geoffrey Murdoch, William Whetsell, Jeffrey Kaye, Maria Manczak.   

Abstract

The objective of our research was to determine synaptic protein levels in brain specimens from AD subjects and age-matched control subjects. Further, to determine whether presynaptic or postsynaptic compartments of neurons are preferentially affected in AD patients, we studied 3 presynaptic vesicle proteins (synaptotagmin, synaptophysin, and Rab 3A), 2 synaptic membrane proteins (Gap 43 and synaptobrevin), and 2 postsynaptic proteins (neurogranin and synaptopodin) in specimens from AD and age-matched control brains. Two brain regions--the frontal and parietal cortices--were assessed for protein levels by immunoblotting analysis. We found a loss of both presynaptic vesicle proteins and postsynaptic proteins in all brain specimens from AD patients compared to those from age-matched control subjects. Further, we found that the loss of synaptic proteins was more severe in the frontal cortex brain specimens than in the parietal cortex brain specimens from the AD subjects compared to those from the control subjects, suggesting that the frontal brain may be critical for synaptic function in AD. Using immunohistochemistry techniques, we also determined the distribution pattern of all synaptic proteins in both the frontal and parietal cortices brain specimens from control subjects. Of the 7 synaptic proteins studied, the presynaptic proteins synaptophysin and rab 3A and the postsynaptic protein synaptopodin were the most down-regulated. Our study suggests that postsynaptic proteins and presynaptic proteins are important for synaptic function and may be related to cognitive impairments in AD.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15851848     DOI: 10.3233/jad-2005-7203

Source DB:  PubMed          Journal:  J Alzheimers Dis        ISSN: 1387-2877            Impact factor:   4.472


  150 in total

1.  Lipolysaccharide-Induced Neuroinflammation Is Associated with Alzheimer-Like Amyloidogenic Axonal Pathology and Dendritic Degeneration in Rats.

Authors:  Xiaohua Deng; Meili Li; Weiming Ai; Lixin He; Dahua Lu; Peter R Patrylo; Huaibin Cai; Xuegang Luo; Zhiyuan Li; Xiaoxin Yan
Journal:  Adv Alzheimer Dis       Date:  2014-06

Review 2.  Synapse loss in dementias.

Authors:  Ryan Clare; Victoria G King; Martin Wirenfeldt; Harry V Vinters
Journal:  J Neurosci Res       Date:  2010-08-01       Impact factor: 4.164

3.  An investigation of the molecular mechanisms engaged before and after the development of Alzheimer disease neuropathology in Down syndrome: a proteomics approach.

Authors:  Giovanna Cenini; Ada Fiorini; Rukhsana Sultana; Marzia Perluigi; Jian Cai; Jon B Klein; Elizabeth Head; D Allan Butterfield
Journal:  Free Radic Biol Med       Date:  2014-08-20       Impact factor: 7.376

4.  Amyloid beta, mitochondrial dysfunction and synaptic damage: implications for cognitive decline in aging and Alzheimer's disease.

Authors:  P Hemachandra Reddy; M Flint Beal
Journal:  Trends Mol Med       Date:  2008-01-22       Impact factor: 11.951

5.  Cellular, synaptic, and biochemical features of resilient cognition in Alzheimer's disease.

Authors:  Steven E Arnold; Natalia Louneva; Kajia Cao; Li-San Wang; Li-Ying Han; David A Wolk; Selamawit Negash; Sue E Leurgans; Julie A Schneider; Aron S Buchman; Robert S Wilson; David A Bennett
Journal:  Neurobiol Aging       Date:  2012-05-02       Impact factor: 4.673

6.  Hippocampal mutant APP and amyloid beta-induced cognitive decline, dendritic spine loss, defective autophagy, mitophagy and mitochondrial abnormalities in a mouse model of Alzheimer's disease.

Authors:  Maria Manczak; Ramesh Kandimalla; Xiangling Yin; P Hemachandra Reddy
Journal:  Hum Mol Genet       Date:  2018-04-15       Impact factor: 6.150

7.  Beta-amyloid causes depletion of synaptic vesicles leading to neurotransmission failure.

Authors:  Jorge Parodi; Fernando J Sepúlveda; Jorge Roa; Carlos Opazo; Nibaldo C Inestrosa; Luis G Aguayo
Journal:  J Biol Chem       Date:  2009-11-13       Impact factor: 5.157

8.  Apolipoprotein E highly correlates with AbetaPP- and tau-related markers in human cerebrospinal fluid.

Authors:  Simona Vuletic; Ge Li; Elaine R Peskind; Hal Kennedy; Santica M Marcovina; James B Leverenz; Eric C Petrie; Virginia M-Y Lee; Douglas Galasko; Gerard D Schellenberg; John J Albers
Journal:  J Alzheimers Dis       Date:  2008-11       Impact factor: 4.472

Review 9.  Amyloid-Beta and Phosphorylated Tau Accumulations Cause Abnormalities at Synapses of Alzheimer's disease Neurons.

Authors:  Ravi Rajmohan; P Hemachandra Reddy
Journal:  J Alzheimers Dis       Date:  2017       Impact factor: 4.472

10.  Alzheimer's disease: synaptic dysfunction and Abeta.

Authors:  Ganesh M Shankar; Dominic M Walsh
Journal:  Mol Neurodegener       Date:  2009-11-23       Impact factor: 14.195

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.